Maternal History of Peripartum Cardiomyopathy and Fetal Echocardiography
No, a maternal history of peripartum cardiomyopathy (PPCM) is NOT a standard indication for fetal echocardiography based on current guidelines. PPCM is an acquired maternal cardiac condition that develops during late pregnancy or postpartum, not an inherited structural cardiac defect that would affect fetal cardiac development.
Why Fetal Echocardiography Is Not Indicated
The 2011 ESC guidelines on cardiovascular diseases during pregnancy 1 do not list maternal PPCM as an indication for fetal echocardiography. The guideline specifies that fetal echocardiography is recommended when:
- There is a family history of congenital heart disease (structural cardiac malformations)
- Maternal medical conditions that increase risk of fetal cardiac anomalies exist
- Fetal cardiac abnormalities are suspected on routine ultrasound
PPCM is fundamentally different from these scenarios because:
- It is not a congenital condition - PPCM develops as an acquired cardiomyopathy in previously healthy women
- It does not cause fetal structural heart defects - The condition affects maternal cardiac function, not fetal cardiac development
- The pathophysiology is maternal-specific - Related to pregnancy-associated hemodynamic stress, not genetic cardiac malformations
Important Caveat: Familial Dilated Cardiomyopathy
There is one critical exception to consider: If the maternal "PPCM" was actually familial dilated cardiomyopathy (FDC) unmasked by pregnancy, then fetal echocardiography may be warranted. The 2010 ESC Heart Failure Association position statement 2 emphasizes that distinguishing true PPCM from pre-existing FDC is essential, as FDC has genetic implications.
Red flags suggesting FDC rather than true PPCM include:
- Positive family history of dilated cardiomyopathy in first-degree relatives
- Presentation during the second trimester (rather than late third trimester or postpartum)
- Larger cardiac dimensions at presentation
- Failure to recover cardiac function within 6-12 months
If FDC is suspected based on family history, genetic testing of the mother should be pursued, and if a pathogenic variant is identified, fetal echocardiography could be considered, though even then, dilated cardiomyopathy typically manifests later in life, not in utero.
What Maternal Monitoring IS Indicated
While fetal echocardiography is not indicated, the mother with prior PPCM requires:
- Preconception counseling about recurrence risk (up to 25-50% in subsequent pregnancies)
- Baseline echocardiography before pregnancy to assess current cardiac function
- Serial maternal echocardiography during pregnancy (second trimester, third trimester, and postpartum) to detect early signs of recurrent dysfunction 2
- Multidisciplinary care involving cardiology, maternal-fetal medicine, and anesthesiology 3
The recent case report 4 highlighting familial predisposition underscores the importance of detailed family history, but this relates to genetic counseling and maternal risk stratification, not routine fetal cardiac imaging.